Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, Szczecin, Poland.
Department of Physiology, Pomeranian Medical University, Powstancow Wlkp. 72, 70-111, Szczecin, Poland.
Arch Immunol Ther Exp (Warsz). 2018 Feb;66(1):65-72. doi: 10.1007/s00005-017-0475-5. Epub 2017 May 23.
Ficolin-2 is an activator of the complement system that acts via the lectin pathway. Complement activation plays a substantial role in the renal injury inherent to kidney transplantation. In this study, we examined the associations between ficolin-2 gene polymorphisms in exon 8 and kidney allograft function. This study comprised 270 Caucasian deceased-donor renal transplant recipients. The following parameters were recorded in each case: delayed graft function (DGF), acute rejection (AR), and chronic allograft dysfunction. Among patients with DGF, we observed a significantly increased frequency of rs7851696 GT and TT genotypes as well as T allele (TT + GT vs GG OR 1.98, 95% CI 1.12-3.48, p = 0.02; T vs G OR 2.08, 95% CI 1.27-3.41, p = 0.005). There was also an increased frequency of rs4521835 GG and TG genotypes as well as G alleles; however, these differences were on the borderline of statistical significance (GG + TG vs TT, OR 1.75, 95% CI 0.98-3.12, p = 0.07; G vs T OR 1.45, 95% CI 1.00-2.09, p = 0.050). In addition, we observed an increased frequency of acute allograft rejection in carriers of ficolin-2 rs7851696 T alleles on the borderline of statistical significance (TT + GT vs GG OR 1.75, 95% CI 0.97-3.16, p = 0.08), but the frequency of T allele was significantly higher in patients with AR (T vs G OR 1.71, 95% CI 1.02-2.87, p = 0.048). The results of our study suggest that ficolin-2 rs7851696 gene polymorphism influences kidney allograft functions, with T allele increasing the risk of DGF and AR.
甘露聚糖结合凝集素 2 是补体系统的激活物,通过凝集素途径发挥作用。补体激活在肾移植中固有肾损伤中起着重要作用。在这项研究中,我们研究了外显子 8 中的 ficolin-2 基因多态性与肾移植功能的关系。这项研究包括 270 名白人尸肾移植受者。在每个病例中记录了以下参数:延迟移植物功能(DGF)、急性排斥(AR)和慢性移植物功能障碍。在 DGF 患者中,我们观察到 rs7851696 GT 和 TT 基因型以及 T 等位基因(TT+GT 与 GG 相比,OR 1.98,95%CI 1.12-3.48,p=0.02;T 与 G 相比,OR 2.08,95%CI 1.27-3.41,p=0.005)的频率显著增加。rs4521835 GG 和 TG 基因型以及 G 等位基因的频率也增加;然而,这些差异处于统计学意义的边缘(GG+TG 与 TT 相比,OR 1.75,95%CI 0.98-3.12,p=0.07;G 与 T 相比,OR 1.45,95%CI 1.00-2.09,p=0.050)。此外,我们观察到 ficolin-2 rs7851696 T 等位基因携带者的急性移植物排斥反应频率增加,处于统计学意义的边缘(TT+GT 与 GG 相比,OR 1.75,95%CI 0.97-3.16,p=0.08),但 AR 患者的 T 等位基因频率明显更高(T 与 G 相比,OR 1.71,95%CI 1.02-2.87,p=0.048)。我们的研究结果表明,ficolin-2 rs7851696 基因多态性影响肾移植功能,T 等位基因增加 DGF 和 AR 的风险。